The Quantellect read.As of Nov 19, 2026, 3 active firms cover Carter Bank and Trust: 0 rate it Buy or better, 3 sit at Neutral, and 0 rate it Sell or worse, a neutral consensus. Targets are tightly clustered, $27.00 to $30.00, so the covering firms are broadly aligned. The average target of $28.50 sits 1% below the current $28.91. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.57 next quarter toward $2.50 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS3 active firms
Neutral
Strong Buy00%
Buy00%
Neutral3100%
Sell00%
Strong Sell00%
Based on 3 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$28.50
-1.4% downside
Average target across 2 active firms as of Nov 19, 2026 vs $28.91 current
Highest Target$30.00
Average Target$28.50
Lowest Target$27.00
Detailed analyst forecasts for CARE
Showing 1–3 of 3 named analysts shown · 3 active firms in the rating projection
As of Nov 19, 2026, 0 of 3 active firms rate CARE a Buy (3 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
CARE EPS & revenue forecast
EPS · NEXT QUARTER
$0.57
Range $0.55 – $0.60 · 4 analysts · +42% YoY
Next period, 4 analysts expect Carter Bank and Trust to earn $0.57 a share (range $0.55 – $0.60), versus $0.40 a year earlier. Full-year consensus is $4.88, growing to $2.50 the year after.
REVENUE · NEXT QUARTER
$46.6M
Range $43.3M – $48.2M · 4 analysts · -56% YoY
Revenue is expected to reach $46.6M (range $43.3M – $48.2M), -56.4% year-over-year. Full-year consensus is $258.3M, rising to $201.7M next year.
Top analysts covering Carter Bank and Trust
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on CARE.
#1
Steve Moss
Raymond James · Rank #119
Neutral
No targeton CARE
Overall win rate
48%
+ Follow
#2
FS
Feddie Strickland
Hovde Group
Neutral
$34.50+19.3% to target
Coverage
—
+ Follow
#3
MP
Mikhail Paramonov
Freedom Broker
Neutral
$27.00-6.6% to target
Coverage
—
+ Follow
#4
MP
Mikhail Paramonov
Freedom Capital Markets
Neutral
$27.00-6.6% to target
Coverage
—
+ Follow
CARE stock forecast FAQ
What is CARE's average 12-month price target?+
The 2 active firms with a live target average $28.50 for Carter Bank and Trust over the next 12 months, ranging from a $30.00 high to a $27.00 low, as of Nov 19, 2026.
Is CARE stock a Buy, Sell or Neutral right now?+
The current consensus is Neutral. Of the 3 active firms as of Nov 19, 2026, 0 rate it Buy or Strong Buy, 3 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for CARE?+
The Street-high target is $30.00 (Hovde Group), and the Street-low is $27.00 (Freedom Broker). The average of all 2 active-firm targets is $28.50.
How many active Wall Street firms cover CARE?+
3 active firms have a recognized rating on Carter Bank and Trust as of Nov 19, 2026, and 2 active firms carry a live 12-month price target.
Who is the most accurate analyst covering CARE?+
Among analysts who currently cover CARE, Steve Moss of Raymond James has the strongest overall Quantellect track record (Rank #119). Their current call is Neutral.
What is Carter Bank and Trust's projected EPS for next quarter?+
The consensus estimate is $0.57 per share (range $0.55 – $0.60) across 4 analysts. Full-year EPS is projected at $4.88, rising to $2.50 the following year.
How much revenue is Carter Bank and Trust expected to report next quarter?+
Consensus revenue is $46.6M (range $43.3M – $48.2M). Full-year revenue is projected at $258.3M, growing to $201.7M next year.
Have analysts been upgrading or downgrading CARE lately?+
As of Nov 19, 2026, 0 of 3 active firms rate CARE a Buy (3 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their CARE calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.